Skip to content

OBSERVATION OF HAEMODYNAMIC RESPONSE TO PREGABALINE IN LAPROSCOPIC CHOLECYSTECTOMY SURGERY

Study to determine the effect of oral pregabaline premedication on haemodynamic response to laryngoscopy and CO2 insufflation during laproscopic cholecystectomy

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2018/06/014428
Enrollment
100
Registered
2018-06-05
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- american society of anaesthesiology physical status 1 and 2

Interventions

Intervention1: pregabalin: Dose-150 mg Frequency and duration- only once 1 hour before surgery Route of administration- Oral properties-GABA agonist anxiolytic, analgesic, anticonvulsant Control Inter

Sponsors

kasturba medical college manipal
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: .ASA grade 1 & 2 .Aged 18 to 65 years .Undergoing elective laparoscopic cholecystectomy under general anaesthesia. .CO2 pneumoperitoneum of atleast 30 minutes duration

Exclusion criteria

Exclusion criteria: 1)Known or suspected allergy to Pregabalin. 2)History of uncontrolled hypertension 3)ASA PS 3/4 patients 4)Cognitive impairement, h/o dizziness 5)Currently using sedatives or anti convulsants 6)Preoperative anticipated difficult air way 7)Layngoscopy duration of >30 seconds or more than 1 attempt of laryngoscopy

Design outcomes

Primary

MeasureTime frame
To observe the efficacy of preoperative oral pregabalin 150 mg on the haemodynamic response to laryngoscopy, intubation and carboperitoneum during laparoscopic cholecystectomyTimepoint: 1)Before premedication 2)1 hour after premdication 3)Following intubation 4)1st minute 5)2nd minute 6)3rd minute 7)4th minute 8)5th minute 9)Before carboperitoneum 10)Following carboperitoneum, 11)5 minutes 12)10 minutes 13)15 minutes 14)30 minutes 15)15 minutes following extubation

Secondary

MeasureTime frame
SedationTimepoint: 1)Before premedication, 2)1 hour after premedication, 3)15 minutes following extubation

Countries

India

Contacts

Public ContactDr Hari Krishna Allu

Kasturba medical college and hospital

malavika.muralidhar@gmail.com9844241620

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026